Cargando…
Measuring and Quantifying Collateral Information in Psychiatry: Development and Preliminary Validation of the McLean Collateral Information and Clinical Actionability Scale
BACKGROUND: The review of collateral information is an essential component of patient care. Although this is standard practice, minimal research has been done to quantify collateral information collection and to understand how collateral information translates to clinical decision making. To address...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082386/ https://www.ncbi.nlm.nih.gov/pubmed/33851928 http://dx.doi.org/10.2196/25050 |
_version_ | 1783685833509830656 |
---|---|
author | Owoyemi, Praise Salcone, Sarah King, Christopher Kim, Heejung Julie Ressler, Kerry James Vahia, Ipsit Vihang |
author_facet | Owoyemi, Praise Salcone, Sarah King, Christopher Kim, Heejung Julie Ressler, Kerry James Vahia, Ipsit Vihang |
author_sort | Owoyemi, Praise |
collection | PubMed |
description | BACKGROUND: The review of collateral information is an essential component of patient care. Although this is standard practice, minimal research has been done to quantify collateral information collection and to understand how collateral information translates to clinical decision making. To address this, we developed and piloted a novel measure (the McLean Collateral Information and Clinical Actionability Scale [M-CICAS]) to evaluate the types and number of collateral sources viewed and the resulting actions made in a psychiatric setting. OBJECTIVE: This study aims to test the feasibility of the M-CICAS, validate this measure against clinician notes via medical records, and evaluate whether reviewing a higher volume of collateral sources is associated with more clinical actions taken. METHODS: For the M-CICAS, we developed a three-part instrument, focusing on measuring collateral sources reviewed, clinical actions taken, and shared decision making between the clinician and patient. To determine feasibility and preliminary validity, we piloted this measure among clinicians providing psychotherapy at McLean Hospital. These clinicians (n=7) completed the M-CICAS after individual clinical sessions with 89 distinct patient encounters. Scales were completed by clinicians only once for each patient during routine follow-up visits. After clinicians completed these scales, researchers conducted chart reviews by completing the M-CICAS using only the clinician’s corresponding note from that session. For the analyses, we generated summary scores for the number of collateral sources and clinical actions for each encounter. We examined Pearson correlation coefficients to assess interrater reliability between clinicians and chart reviewers, and simple univariate regression modeling followed by multilevel mixed effects regression modeling to test the relationship between collateral information accessed and clinical actions taken. RESULTS: The study staff had high interrater reliability on the M-CICAS for the sources reviewed (r=0.98; P<.001) and actions taken (r=0.97; P<.001). Clinician and study staff ratings were moderately correlated and statistically significant on the M-CICAS summary scores for the sources viewed (r=0.24, P=.02 and r=0.25, P=.02, respectively). Univariate regression modeling with a two-tailed test demonstrated a significant association between collateral sources and clinical actions taken when clinicians completed the M-CICAS (β=.27; t(87)=2.47; P=.02). The multilevel fixed slopes random intercepts model confirmed a significant association even when accounting for clinician differences (β=.23; t(57)=2.13; P=.04). CONCLUSIONS: This pilot study established the feasibility and preliminary validity of the M-CICAS in assessing collateral sources and clinical decision making in psychiatry. This study also indicated that reviewing more collateral sources may lead to an increased number of clinical actions following a session. |
format | Online Article Text |
id | pubmed-8082386 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | JMIR Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-80823862021-05-06 Measuring and Quantifying Collateral Information in Psychiatry: Development and Preliminary Validation of the McLean Collateral Information and Clinical Actionability Scale Owoyemi, Praise Salcone, Sarah King, Christopher Kim, Heejung Julie Ressler, Kerry James Vahia, Ipsit Vihang JMIR Ment Health Original Paper BACKGROUND: The review of collateral information is an essential component of patient care. Although this is standard practice, minimal research has been done to quantify collateral information collection and to understand how collateral information translates to clinical decision making. To address this, we developed and piloted a novel measure (the McLean Collateral Information and Clinical Actionability Scale [M-CICAS]) to evaluate the types and number of collateral sources viewed and the resulting actions made in a psychiatric setting. OBJECTIVE: This study aims to test the feasibility of the M-CICAS, validate this measure against clinician notes via medical records, and evaluate whether reviewing a higher volume of collateral sources is associated with more clinical actions taken. METHODS: For the M-CICAS, we developed a three-part instrument, focusing on measuring collateral sources reviewed, clinical actions taken, and shared decision making between the clinician and patient. To determine feasibility and preliminary validity, we piloted this measure among clinicians providing psychotherapy at McLean Hospital. These clinicians (n=7) completed the M-CICAS after individual clinical sessions with 89 distinct patient encounters. Scales were completed by clinicians only once for each patient during routine follow-up visits. After clinicians completed these scales, researchers conducted chart reviews by completing the M-CICAS using only the clinician’s corresponding note from that session. For the analyses, we generated summary scores for the number of collateral sources and clinical actions for each encounter. We examined Pearson correlation coefficients to assess interrater reliability between clinicians and chart reviewers, and simple univariate regression modeling followed by multilevel mixed effects regression modeling to test the relationship between collateral information accessed and clinical actions taken. RESULTS: The study staff had high interrater reliability on the M-CICAS for the sources reviewed (r=0.98; P<.001) and actions taken (r=0.97; P<.001). Clinician and study staff ratings were moderately correlated and statistically significant on the M-CICAS summary scores for the sources viewed (r=0.24, P=.02 and r=0.25, P=.02, respectively). Univariate regression modeling with a two-tailed test demonstrated a significant association between collateral sources and clinical actions taken when clinicians completed the M-CICAS (β=.27; t(87)=2.47; P=.02). The multilevel fixed slopes random intercepts model confirmed a significant association even when accounting for clinician differences (β=.23; t(57)=2.13; P=.04). CONCLUSIONS: This pilot study established the feasibility and preliminary validity of the M-CICAS in assessing collateral sources and clinical decision making in psychiatry. This study also indicated that reviewing more collateral sources may lead to an increased number of clinical actions following a session. JMIR Publications 2021-04-14 /pmc/articles/PMC8082386/ /pubmed/33851928 http://dx.doi.org/10.2196/25050 Text en ©Praise Owoyemi, Sarah Salcone, Christopher King, Heejung Julie Kim, Kerry James Ressler, Ipsit Vihang Vahia. Originally published in JMIR Mental Health (http://mental.jmir.org), 14.04.2021. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Mental Health, is properly cited. The complete bibliographic information, a link to the original publication on http://mental.jmir.org/, as well as this copyright and license information must be included. |
spellingShingle | Original Paper Owoyemi, Praise Salcone, Sarah King, Christopher Kim, Heejung Julie Ressler, Kerry James Vahia, Ipsit Vihang Measuring and Quantifying Collateral Information in Psychiatry: Development and Preliminary Validation of the McLean Collateral Information and Clinical Actionability Scale |
title | Measuring and Quantifying Collateral Information in Psychiatry: Development and Preliminary Validation of the McLean Collateral Information and Clinical Actionability Scale |
title_full | Measuring and Quantifying Collateral Information in Psychiatry: Development and Preliminary Validation of the McLean Collateral Information and Clinical Actionability Scale |
title_fullStr | Measuring and Quantifying Collateral Information in Psychiatry: Development and Preliminary Validation of the McLean Collateral Information and Clinical Actionability Scale |
title_full_unstemmed | Measuring and Quantifying Collateral Information in Psychiatry: Development and Preliminary Validation of the McLean Collateral Information and Clinical Actionability Scale |
title_short | Measuring and Quantifying Collateral Information in Psychiatry: Development and Preliminary Validation of the McLean Collateral Information and Clinical Actionability Scale |
title_sort | measuring and quantifying collateral information in psychiatry: development and preliminary validation of the mclean collateral information and clinical actionability scale |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082386/ https://www.ncbi.nlm.nih.gov/pubmed/33851928 http://dx.doi.org/10.2196/25050 |
work_keys_str_mv | AT owoyemipraise measuringandquantifyingcollateralinformationinpsychiatrydevelopmentandpreliminaryvalidationofthemcleancollateralinformationandclinicalactionabilityscale AT salconesarah measuringandquantifyingcollateralinformationinpsychiatrydevelopmentandpreliminaryvalidationofthemcleancollateralinformationandclinicalactionabilityscale AT kingchristopher measuringandquantifyingcollateralinformationinpsychiatrydevelopmentandpreliminaryvalidationofthemcleancollateralinformationandclinicalactionabilityscale AT kimheejungjulie measuringandquantifyingcollateralinformationinpsychiatrydevelopmentandpreliminaryvalidationofthemcleancollateralinformationandclinicalactionabilityscale AT resslerkerryjames measuringandquantifyingcollateralinformationinpsychiatrydevelopmentandpreliminaryvalidationofthemcleancollateralinformationandclinicalactionabilityscale AT vahiaipsitvihang measuringandquantifyingcollateralinformationinpsychiatrydevelopmentandpreliminaryvalidationofthemcleancollateralinformationandclinicalactionabilityscale |